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Radiation dose in CT colonography–trends
in time and differences between daily practice
and screening protocols
Abstract The purpose of this study
was to evaluate the currently used
effective doses in CT colonography
(CTC) and to search for trends in time.
A Pubmed search for articles and a
search for congress abstracts con-
cerning CTC was performed.
Research institutions were sent a CTC
dose questionnaire concerning the
type of CT system employed and
the CT parameters used. With the
ImPACT CT Dosimetry Spreadsheet
effective doses were calculated. Of 83
institutions, 34 returned a complete
questionnaire; 21 (62%) used 64-
detector row CT and 17 (50%) used
dose modulation. The median effec-
tive dose per institution was 5.7 mSv
(2.8 mSv supine; 2.5 mSv prone) for
screening protocols and 9.1 mSv (5.2
and 3.0 mSv, respectively) for daily
practice protocols (p<0.05). Doses
did not differ significantly between
CT machines with different numbers
of detector rows. In 17 institutions
incorporated in a study in 2004 as
well, the median dose for daily prac-
tice protocols changed from 11 mSv in
2004 to 9.7 mSv now (n.s.). Median
effective dose for CTC is significantly
lower for screening than for daily
practice protocols. Although the
number of CTC protocols with dose
modulation increased substantially
since 2004, no significant decrease in
effective dose was found.
Keywords CT colonography .
Radiation dose . Colorectal
neoplasms . Computed tomography
Introduction
Currently, multi-detector computed tomography (CT)
systems with a large number of detector rows (e.g., 40 or
64), dose modulation or automated current selection (ACS)
is widely used for all applications including CT colonog-
raphy (CTC). These technical improvements will have an
effect on image quality, but also on radiation exposure.
Dose efficiency is improved with an increasing number of
detector rows due to the decrease of the effect of
overbeaming, which is the additional radiation due to the
penumbra effect [1]. On the other hand, dose efficiency is
lost with machines with a larger number of detector rows,
because of increased amount of overranging, which is the
difference between the exposed length and the planned
length of the CT examination [2, 3]. ACS automatically
adjusts the tube current to the size of the patient to reduce
the differences in noise level between thin and thicker
patients. Differences in image quality will therefore be
reduced for patients of different sizes [4]. Dose modulation
adjusts the tube current according to the changing patient
anatomy. This can give an overall reduction in dose level
per patient, while the image quality is preserved [5, 6].
For CTC it is important to reduce radiation dose for
optimization of the benefit-risk ratio of the examination,
especially when used in low-risk screening patients. The
life-time cancer risk associated with the radiation exposure
using a typical current CT technique for paired (supine and
prone) CTC was estimated to be 0.14% for a 50 year old,
which might be reduced by factors of 5 or even 10 with
optimized CTC protocols [7]. Important is however to
identify acceptable thresholds of image quality so that
radiation dose optimization can take place [4]. In earlier
research it was found that with low doses still good image
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quality and high diagnostic accuracy were obtained at CTC
[8–11].
In a previous study the effective radiation dose in CTC
protocols of 28 research institutions was surveyed [12].
Most institutions at that time used CT systems with 4, 8 or
16 detector arrays. The median effective dose per insti-
tution was 5.1 mSv per position and 10.2 mSv in total. No
CT systems with more than 16 detector rows, no dose
modulation or automated current selection were used at that
time. The aim of the present study was to investigate the
current effective dose for CTC in daily practice and
screening protocols and to compare doses for the protocols
used with machines using different numbers of detector
rows. Furthermore, current effective doses were compared
with the results of the former dose evaluation study.
Methods
Dose questionnaire
A Pubmed search was performed with MESH heading ‘CT
colonography,’ and all articles published from January
2004 until January 2007 describing a study on CTC
accuracy were selected. Articles in a language other than
English or case reports were excluded. Furthermore, all
abstracts of the Congress of the Radiological Society of
North America (RSNA) 2006, European Congress of
Radiology (ECR) 2006 and the Symposium on Virtual
Colonoscopy in Boston 2006 were searched for studies
with CTC. In addition all institutions that were invited for a
questionnaire in the study by Jensch et al. [12] were
included, if this was not yet the case. All selected
institutions received a mail in which they were invited to
fill in a questionnaire. Reminder e-mails were sent after
4 and 7 weeks. In Table 1 the questions of the dose
evaluation questionnaire are listed. The data for the present
study were collected between April and September 2007.
Estimation of effective doses
The effective dose for each protocol was estimated using
the ImPACTCTDosimetry Spreadsheet (www.impactscan.
org/ctdosimetry.htm) [13, 14]. With this spreadsheet
effective doses can be calculated for a hermaphrodite with
a length of 170 cm and a weight of 70 kg [15]. In the
calculation of effective dose, a nominal scan trajectory of
43 cmwas assumed (from the diaphragm to the groin). Data
for the additional anatomical length exposed due to
overranging were obtained from the CT-Expo spreadsheet,
and the effective length of the volume examinedwas used in
the calculation of the effective dose [16].
Calculation of effective dose is straightforward for
the situation without ACS or dose modulation. With ACS
the tube current is constant, but depends on the size of the
patient, and with dose modulation the tube current also
varies per slice and per tube angle (in case X/Y modulation
is used), which complicates the calculations of effective
dose. In this situation we used the average effective mAs
value that was used for a CTC of an average-sized patient
of 170 cm and 70 kg. In case not the effective mAs, but the
CTDIvol was provided, the average effective mAs was
obtained from the ImPACT spreadsheet; when the dose-
length product (DLP) was provided the CTDIvol was
obtained by dividing by the length of the volume exam-
ined. In case data for patients of deviant weight were
provided, the effective mAs value for a patient of 70 kg was
Table 1 Questions in the dose evaluation questionnaire
Daily practice protocol? y/n




Type of CT scanner: (Manufacturer and type)
Number of slices: 1, 2, 4, 8, 16, 40 or 64
Collimation per slice: ...mm
Tube voltage: ...kV
Rotation time: ...s
Pitch (table feed per rotation/
total collimation):
...
For scans without automatic current selection or dose modulation:
-Tube current: or ...mA
-Tube current × rotation time: or ...mAs
-Tube current × rotation time/
Pitch:
...effective mAs or mAs per slice
For scans with automatic current selection and/or dose modulation (for
an average male patient, i.e., approximately 170 cm and 70 kg):
-Length patient: ...cm
-Weight patient: ...kg
-Preset or reference mAs
(if available)
...mAs
-Realized DLP: and/or ...mGy*cm
-Realized average mAs: and/or ...mAs
-Realized CTDI vol: ...mGy
-Length of scan or scans: ...cm
-Use of X/Y modulation: y/n
-Use of Z modulation: y/n
Institutions were asked to complete the form for both supine and
prone protocols and for the daily practice and screening protocols
(or only one protocol if not both in use). Indications for daily
practice patients were: (1) symptomatic patients with symptoms of
colorectal cancer or other colorectal disease, (2) surveillance patients
for repeat examination on colorectal cancer or other colorectal
disease or (3) DLP: dose length product. CTDIvol: computed
tomography dose index
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estimated with an empirical relationship, using data of
Kalra et al. [17] (see Fig. 1).
Data of the CTC protocols for daily practice and
screening were evaluated separately, and classified accord-
ing to the number of detector rows of the CT machine in
question. When an institution used protocols with and
without dose modulation, the protocols with dose modu-
lation were used. However, when an institution used more
than one protocol for daily practice or screening that
differed otherwise, both protocols were used, and the
average effective dose for the institution was calculated.
Results of dose calculations were sent to all institutions to
check for possible errors.
Of the institutions that returned a questionnaire in a
former CTC dose evaluation study as well [12], com-
parisons were made between the effective dose at that time
(2004) and now. At that time overranging was not taken
into account and therefore we recalculated the effective
doses for this study including the effect of overranging.
The number and percentages of multi-detector row CT
systems with a different number of detector rows were
calculated for 2004 and 2007, as were the number of
institutions that used dose modulation in 2007.
Sensitivity analysis parameters dose modulation
We performed a sensitivity analysis to determine the
influence of deviations in our data or assumptions in case
of dose modulation on the outcomes of the study.
The above-mentioned correction of mAs values for
patients of deviant weight are only approximate; it is
known that this correction is different for different CT
manufacturers, and even within one CT model the mA-
weight curve can to a certain extent be adjusted [18, 19].
We checked the influence of the choice of the correction by
Fig. 1 Example of relation of tube current and weight in CT
systems when dose modulation is applied
Fig. 2 Indications for CTC examinations for daily practice
protocols in 33 institutions
Table 2 Corrections of mAs values according to weight in 6
institutions
Positiona Weight (kg) mAs mAsb
Daily practice
Berlin Supine/prone 75 56 49
Leuven Prone 80 15 12
London Supine/prone 67 113/110 123/120
Perth Supine 75 200 175
Ulm Supine/prone 84 162 113
Screening
Buenos Aires Supine/prone 80 49 38
Leuven Supine 79 51 40
Prone 80 16 12
Ulm Supine/prone 76 49 42
aPosition: patient position where dose modulation is applied. bmAs:
corrected mAs value for weight
Table 3 Daily practice protocols in different institutions with
median values of scan parameters and effective dose per protocol
Number of simultaneously acquired slices
64 40 16 4 1
Number of protocols 21 1 11 4 2
Tube voltage (kV) 120 120 120 120 120
Rotation time (s) 0.5 0.4 0.5 0.5 0.75
Collimation (mm) 0.625 0.625 1.25 1.875 5
Effective mAs 58/50a 113 62/56a 83.5/30.5a 55
Dose modulation 12 1 2 - -
Effective dose (mSv) 9.1 13.7 11.5 9.1 4.2
aResults for median values of collimation and effective mAs for
supine and prone positions (supine/prone)
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recalculating some of the data using 50% less or 50% more
mAs correction for deviant weight than the correction
shown in Fig. 1. We also checked the sensitivity of the
outcomes on our assumption of a patient weight of 70 kg in
case no unambiguous information was provided. If errors
had been made, we assumed that the weight should have
been somewhat larger, and therefore recalculations were
made for weights of 75 and 80 kg.
Statistical analysis
For the effective dose and the various CT parameters,
medians, minimum and maximum values were determined.
The effective doses in the scanners with a different number
of detector rows were compared by using the Kruskal-
Wallis test. Differences between daily practice and screen-
ing protocols and between protocols of 16-, 40- and
64-detector row scanners with and without dose modula-
tion were analyzed with the Wilcoxon-Mann-Whitney test.
For comparison of results of the former study and the
present study, we used the Wilcoxon signed ranks test. A
p-value of less than 0.05 was considered to be significant.
Results
Response
With the search, 83 institutions were identified. After two
reminder e-mails to non-responding institutions, we obtained
a response from 50 institutions (60%), and from these insti-
tutions we received 37 (45%) questionnaires. Five authors
answered that CT colonography was no longer performed,
and eight authors responded positively, but finally did not
return the questionnaire notwithstanding reminder e-mails.
Three authors filled in the questionnaire with insufficient
information for calculation of the effective dose, thus 34
institutions remained with complete questionnaires. Of these
34 institutions, 22 performedCTC for both daily practice and
screening purposes, 11 only for daily practice and 1 insti-
tution only for screening. Indications for patients receiving
CTC examinations in daily practice are indicated in Fig. 2.
Data on dose modulation
Seventeen institutions indicated that they used dose
modulation for protocols for supine or prone scans, or
both. Six of these institutions provided data for patients of
70 kg, and six institutions provided data for patients of
another weight. Table 2 shows these weights, the un-
corrected mAs values and the estimated mAs values for a
patient of 70 kg using the relationship of Fig. 1. Five
institutions did not provide unambiguous information on
weight, and it was assumed that the weight of the patient
was 70 kg.
CT parameters: daily practice and screening protocols
Overall, 37 CT machines were used by 34 institutions; 3
institutions use CT machines from 2 different manufac-
turers. In Table 3 a summary is given of the protocols for
the daily practice patients. No significant differences in
effective dose were found between scanners with different
detector rows and between protocols with and without dose
modulation. The median effective dose in 39 daily practice
protocols was 9.1 mSv (range 2.8–22), 5.2 mSv (1.0–14.1)
for supine and 3.0 mSv (0.6–9.8) for prone CT acquisition.
The median effective dose per institution was also 9.1 mSv
(2.8–22).
The median values for the 25 protocols for screening CT
colonography in 22 institutions are given in Table 4. No
significant difference in effective dose was found between
scanners with different detector rows. The median effective
dose for the screening protocols was 5.6 mSv (range 2.6–
14.7), 2.8 mSv (1.0–6.1) for supine and 2.5 mSv (0.6–9.8)
for prone CT acquisition. The median effective dose per
institution was 5.7 mSv (2.6–12.2). See Fig. 3 for a histo-
Table 4 Screening protocols in different institutions with median
values of scan parameters and effective dose calculations per
protocol
Number of simultaneously acquired slices
64 16 4 1
Number of protocols 13 9 2 1
Tube voltage (kV) 120 120 120 120
Rotation time (s) 0.5 0.5 0.5 0.5
Collimation (mm) 0.6 1.125 1.125 5
Effective mAs 50/36a 40/32a 44 57
Dose modulation 7 5 - -
Effective dose (mSv) 5.8 5.6 7.8 4.3
aResults for median value of effective mAs for supine and prone
(supine/prone)
Fig. 3 Histogram of effective dose in daily practice and screening
protocols
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Table 5 Daily practice protocols



















Amsterdam Philips Brilliance 64 64×0.625 120 0.75 0.984 58 3.2 3.2 6.5
Bari Toshiba Aquillon 16 16×1 120 0.5 0.875 29 3.0 3.0 6.1
Berlin Toshiba Aquillon 64 64×0.5 120 0.5 0.9 48 5.1 5.1 10.1
Boston Siemens Sensation 64 32×0.6 120 0.5 1 205/82b 12.5 5.0 17.4
Buenos Aires Philips Brilliance 64 64×0.625 120 0.5 0.64 50 2.8 2.8 5.5
Candioloa GE Lightspeed 16 16×1.25 120 0.7 1.375 25 2.0 2.0 4.0
GE Lightspeed 16 16×1.25 120 0.7 1.375 178/25b 14.1 2.0 16.1
Chandigarha GE Lightspeed plus 4×2.5 120 0.6 1.5 100/28b 8.0 2.2 10.2
Siemens Sensation 16 16×1.5 120 0.5 1 200/60b 12.4 3.7 16.2
Chesterfielda GE Lightspeed plus 4×2.5 120 0.5 1.5 67/33b 5.3 2.6 8.0
GE Lightspeed Pro 16 16×1.25 120 0.6 1.375 87/65b 7.1 5.3 12.3
Chicago Philips Brilliance 64 64×0.625 120 0.5 1 50 2.8 2.8 5.6
Como GE VCT 64×0.625 120 0.5 0.984 53 5.2 5.2 10.4
Copenhagen GE CT/i 1×5 120 1 1.3 54 2.0 2.0 4.1
Dusseldorf Siemens Sensation 64 32×0.6 120/100b 0.5 1.2 120/20b 7.4 0.7 8.1
Jerusalema Philips MxIDT 16×1.5 120 0.5 1 50/100b 3.0 6.1 9.1
GE VCT 64×0.625 120 0.5 1 50/100b 4.9 9.8 14.7
Latina GE VCT 64×0.625 120 0.5 1.375 116/73b 11.7 7.4 19.0
Lausanne GE VCT 64×0.625 120 0.6 1.375 131/87b 13.2 8.8 22.0
Leuven Siemens Sensation 16 16×0.75 120/140b 0.5 0.9 170/12b 10.6 1.2 11.9
London Siemens Sensation 64 32×0.6 120 0.5 0.95 123/120b 7.4 7.2 14.5
Muenster Siemens Definition 32×0.6 120 0.5 1.2 157/10b 9.0 0.6 9.7
Munich Siemens Sensation 64
Toshiba Aquilion
32×0.6 120 0.5 1.25/1.4b 80/30b 4.9 1.8 6.7
Naples Multi/4 4×1 120 0.5 1.375 109/51b 13.0 6.1 19.1
New York (1) GE Lightspeed 16 16×1.25 120 0.5 1.375 56 4.4 4.4 8.9
New York (2) GE CT/i 1×5 120 0.5 1.5–2.0 57 2.1 2.1 4.3
New York (3) Siemens Sensation 32×0.6/24×
1.2b
120 0.5 1 34 2.1 2.0 4.0
Nonsan Philips MxIDT 16×1.5 120 0.5 0.8–1.0 191/92b 11.5 5.6 17.1
Padova GE Lightspeed 16 16×1.25 120 0.8 1.5 27 2.1 2.1 4.3
Paris Philips Brilliance 64 64×0.625 120 0.5 1.11 100 5.6 5.6 11.2
Pertha Philips Brilliance 64 64×0.625 120 0.4 1.094 40 2.2 2.2 4.5
Philips Brilliance 64 64×0.625 120 0.75/0.4b 0.891/1.094b 174/40b 9.7 2.2 11.9
Pisa GE Light Speed Plus 4×1.25 120 0.5 1.5 17 1.7 1.7 3.3
Rochestera GE LightSpeed 16 16×0.625 120 0.5 1.375 62 5.7 5.7 11.5
Siemens Sensation 64 32×0.6 120 0.5 1.4 43 2.6 2.6 5.3
Roeselare Siemens Sensation 64 32×0.6 140/120b 0.5 1.4 10/30b 1.0 1.9 2.8
Rome Siemens Sensation 64 32×0.6 120 0.5 1 100/50b 6.1 3.0 9.1
San Francisco GE VCT 64×0.625 120 0.5 0.984 38 3.7 3.7 7.5
Ulm Philips Brilliance 40 40×0.625 120 0.4 0.6 113 6.9 6.9 13.7
Median per protocol 5.2 3.0 9.1
aInstitutions that use two scan protocols
bProtocol with different settings for supine and prone (supine/prone). The total effective dose is the sum of the supine and prone dose; for
these calculations the not rounded off numbers are used
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gram of the effective doses of daily practice and screening
protocols.
Overviews of CT parameters and effective dose for daily
practice protocols and screening protocols per institution
are given in Tables 5 and 6. The effective doses for the
screening protocols were significantly lower than for the
daily practice protocols (p=0.007).
Sensitivity analysis parameters dose modulation
Recalculations using 50% less or 50% more mAs correc-
tion than the nominal correction for the six institutions that
provided data for deviant weight (Table 2) produced the
following results: Effective doses per institution remained
the same except for screening protocols in which the
Table 6 Screening protocols

















Bari Toshiba Aquillon 16 16×1 120 0.5 0.875 29 3.0 3.0 6.1
Boston Siemens 32×0.6 120 0.5 0.75 82 4.8 4.8 9.7
Buenos
Aires
Philips Brilliance 64 64×0.6 120 0.5 0.64 38 2.1 2.1 4.2
Candiolo GE Lightspeed 16 16×1.25 120 0.7 1.375 25 2.0 2.0 4.0
Chicago Philips Brilliance 64 64×0.625 120 0.5 1 50 2.8 2.8 5.6
Dusseldorf Siemens Sensation
64
32×0.6 100 0.5 1.2 50/30b 1.6 1.0 2.6
Jerusalema Philips MxIDT 16×1.5 120 0.5 1 100/50b 3.0 6.1 9.1
GE VCT 64×0.625 120 0.5 1 100/50b 4.9 9.8 14.7
Latina GE VCT 64×0.625 120 0.5 1.375 36 3.6 3.6 7.3
Leuven Siemens Sensation
16
16×0.75 120/140b 0.75 0.9 40/12 2.5 1.2 3.8
Madisona GE Lightspeed 16 16×1.25 120 0.5 1.375 32 2.5 2.5 5.1
GE Lightspeed
Pro16
16×1.25 120 0.5 1.375 31 2.5 2.5 5.0
Muenster Siemens Definition 32×0.6 120 0.5 1.2 90/102 5.2 0.6 5.8
Munich Siemens Sensation
64
32×0.6 120 0.5 1.25/1.40b 80/30b 4.9 1.8 6.7
Naples Toshiba Aquilion
Multi/4
4×1 120 0.5 1.375 51 6.1 6.1 12.2
New York (1) GE Lightspeed 16 16×1.25 120 0.5 1.375 56 4.4 4.4 8.9
New York (2) GE CT/i 1×5 120 0.5 1.75 57 2.1 2.1 4.3




120 0.5 1 34 2.1 2.0 4.0
Pisa GE Light Speed Plus 4×1.25 120 0.5 1.5 37 1.7 1.7 3.3
Rochestera GE LightSpeed 16 16×0.625 120 0.5 1.375 62 5.7 5.7 11.5
Siemens Sensation
64
32×0.6 120 0.5 1.4 43 2.6 2.6 5.3
Roeselare Siemens Sensation
64
32×0.6 120 0.5 1.4 10/30b 1.0 1.9 2.8
Rome Siemens Sensation
64
32×0.6 120 0.5 1 100/10b 6.1 0.6 6.7
San Francisco GE VCT 64×0.625 120 0.5 0.984 38 3.7 3.7 7.5
Ulm Philips Mx 8000 16×0.75 120 0.75 1 42 2.8 2.8 5.6
Median per protocol 2.8 2.5 5.6
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median dose for 50% less correction increased from 5.7 to
5.9 mSv. Recalculations for the five institutions that did not
provide unambiguous information on weight resulted in a
reduction of the median effective dose for daily practice
from 9.1 to 8.9 mSv (for 75 kg) and to 8.2 mSv (80 kg) and
for screening from 5.7 to 5.6 mSv and to 5.4 mSv for 75
and 80 kg, respectively.
Overranging planned trajectory of the volume
examined
The increase in dose due to overranging of the planned
trajectory of the volume examined was calculated for each
CT protocol. For 64- and 40-detector-row CT systems the
increase in dose was on the average 14%, for 16-detector-
row CT systems 10% and for 4-detector-row and single-
detector-row CT systems 4%.
Comparison with CTC performed in 2004
We compared effective doses of the 17 institutions that also
responded to our questionnaire in the first study. In this study
only the effective doses for daily practice were determined.
In these institutions the median effective dose for daily
practice was at that time 11.0 mSv (range 4.2–21.0). In these
figures the effect of overranging has been taken into account
[12]. The current median dose in these institutions is
9.7 mSv. This difference is not significant. In the present
study, 17 institutions used dose modulation (50%) together
with automatic current selection, while in 2004 no institution
used this for CTC. Finally we compared the number of
detector rows of the CTsystems used in the earlier study and
now. In 2004, 82% (23/28) of the institutions used a CT
system with fewer than 16 detector rows and 18% (5/28)
used a 16-detector-row CT system. In 2007 only 18% (6/34)
used a CT system with fewer than 16 detector rows and 62%
(21/34) used a 64-detector-row CT system.
Discussion
In this dose evaluation study, we give an overview of the
current protocols and estimates of the effective dose for
CTC. A questionnaire was used to obtain information on
the scanner types and CT parameters that are used at
present for CTC. The effective doses were lower for the
screening protocols than for the daily practice protocols,
with median values of respectively 5.7 and 9.1 mSv (p<
0.05). No differences in effective doses were found for the
different detector row CT systems. The median effective
dose of CTC for the institutions that also were included in
the dose evaluation study of 2004 was slightly lower than
in 2007 (9.7 and 11.0 mSv, respectively), but this differ-
ence was not significant.
It is not unexpected that the effective doses for screening
protocols are lower than for daily practice protocols. When
CTC is used as a screening procedure for patients at
average risk for colorectal cancer, the radiation dose must
be minimized to maintain the appropriate benefit-risk ratio
[20, 21]. An earlier study has shown good diagnostic
accuracy with low tube current protocols. Even for effec-
tive doses considerably less than 1 mSv per CTC exami-
nation (supine and prone), only a minimal, not significant
decrease in sensitivity for polyps of ≥6 mm compared to a
dose level of 10 mSv was found [10]. Other studies have
also shown that CT studies with a lower dose can give
sufficient image quality for polyp detection [8, 22, 23]. In
this study a median dose for screening protocols of 5.6 mSv
was found, with a range of 2.6 to 14.7 mSv. Obviously
there is still ample opportunity for dose reduction in
screening CTC.
The number of CT systems with 16 or more detector
rows now used for CT colonography has increased
considerably in comparison with the previous question-
naire (2004). In this study the effective dose for the 64-
detector-row CT systems did not significantly differ from
that found for 16- and 4-detector-row CT systems: for the
daily practice protocols the dose was 9.1 mSv for 64-
detector-row CT systems and 11.7 and 9.1 mSv for 16- and
4-detector row machines, respectively.
All new CT systems can be operated with dose
modulation with the possibility of dose reduction without
loss of image quality [24]. Half of the institutes now use
dose modulation in their CTC protocols. Until now this
appears not to have resulted in a reduction in effective dose.
In comparison with the effective doses in 2004 of the
former study, the effective doses for daily practice
protocols showed a small, not significant reduction from
11.0 mSv in 2004 to 9.7 mSv at present. The effective
doses for these protocols have thus remained virtually the
same during the last few years. This may have different
reasons. A number of institutions may value a higher image
quality more than a lower dose. This hypothesis is sup-
ported by the large range of effective doses found in the
present study: from less than 3 mSv to more than 20 mSv.
Some of these differences may be explained by differences
in the CT examination, for example, the use of intravenous
contrast medium (which is mostly used for high-risk
patients that require higher image quality) necessitates a
higher dose [25].
This study has some limitations. Only 50 (60%) of the 83
institutions that were found with our search responded. Of
the responding institutions 37 returned the questionnaire
and 5 answered they had stopped performing CTC (in total
51% of all sent e-mails). A reason for not returning the
questionnaire might be difficulties with obtaining the CT
parameters, especially for the institutions that use a CT
protocol with dose modulation.
The accuracy of data obtained with any questionnaire is
never completely reliable, and that is especially the case in
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the present situation for the protocols with dose modula-
tion. Of course more accurate results would have been
obtained if we had examined a humanoid phantom in all
institutions with their CTC protocol(s), but this was
practically not feasible. A first uncertainty is that we
made the approximation to use the average mAs value
(instead of the actual, varying mA value) in the estimation
of the effective dose. This appears to be a reasonable
approximation, however [16]. Secondly, some institutions
provided both effective mAs values and CTDI values and/
or DLP values. In case discrepancies were present between
these values, the effective mAs values were used in the
dose calculations. Only for two institutions larger (>25%)
discrepancies were present, however.
We also performed an analysis to determine how
sensitive the outcomes of the study are for any deviations
in the data or assumptions in case of dose modulation. It
appeared that the influence of the exact relation between
weight and mAs value (Fig. 1) was limited. Also the exact
choice of the weight for 5 of the 17 institutions that used
dose modulation and did not provide unambiguous
information on the weight of the patient influenced the
results only to a limited degree.
Conclusion
The median effective dose for CTC colonography at
present is significantly lower for screening protocols
(5.6 mSv) than for daily practice protocols (9.1 mSv),
which is important because of differences in benefit-risk
ratios for patients in screening and in daily practice. We
found that the use of CT systems with a different number of
detector rows does not influence the effective dose.
Furthermore, the current effective dose has not signifi-
cantly changed compared to the dose in 2004, but the
number of CTC protocols with dose modulation increased
substantially.
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